427 related articles for article (PubMed ID: 24118677)
1. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
Skorupski KA; Uhl JM; Szivek A; Allstadt Frazier SD; Rebhun RB; Rodriguez CO
Vet Comp Oncol; 2016 Mar; 14(1):81-7. PubMed ID: 24118677
[TBL] [Abstract][Full Text] [Related]
2. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).
Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240
[TBL] [Abstract][Full Text] [Related]
3. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma.
Selmic LE; Burton JH; Thamm DH; Withrow SJ; Lana SE
J Vet Intern Med; 2014; 28(2):554-63. PubMed ID: 24512451
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
[TBL] [Abstract][Full Text] [Related]
5. The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro.
Marley K; Helfand SC; Edris WA; Mata JE; Gitelman AI; Medlock J; Séguin B
BMC Vet Res; 2013 Jan; 9():15. PubMed ID: 23331343
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
[TBL] [Abstract][Full Text] [Related]
7. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs.
Kent MS; Strom A; London CA; Seguin B
J Vet Intern Med; 2004; 18(4):540-4. PubMed ID: 15320595
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and efficacy of a novel doxorubicin and carboplatin chemotherapy protocol for the treatment of canine appendicular osteosarcoma following limb amputation.
Lane A; Black M; Wyatt K
Aust Vet J; 2012 Mar; 90(3):69-74. PubMed ID: 22339117
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma.
Kozicki AR; Robat C; Chun R; Kurzman ID
Vet Comp Oncol; 2015 Sep; 13(3):229-36. PubMed ID: 23663234
[TBL] [Abstract][Full Text] [Related]
10. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
York D; Withers SS; Watson KD; Seo KW; Rebhun RB
Vet Comp Oncol; 2017 Sep; 15(3):1087-1100. PubMed ID: 27333821
[TBL] [Abstract][Full Text] [Related]
11. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.
Phillips B; Powers BE; Dernell WS; Straw RC; Khanna C; Hogge GS; Vail DM
J Am Anim Hosp Assoc; 2009; 45(1):33-8. PubMed ID: 19122062
[TBL] [Abstract][Full Text] [Related]
12. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
London CA; Gardner HL; Mathie T; Stingle N; Portela R; Pennell ML; Clifford CA; Rosenberg MP; Vail DM; Williams LE; Cronin KL; Wilson-Robles H; Borgatti A; Henry CJ; Bailey DB; Locke J; Northrup NC; Crawford-Jakubiak M; Gill VL; Klein MK; Ruslander DM; Thamm DH; Phillips B; Post G
PLoS One; 2015; 10(4):e0124889. PubMed ID: 25923466
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy.
Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ
J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973
[TBL] [Abstract][Full Text] [Related]
14. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006).
Saam DE; Liptak JM; Stalker MJ; Chun R
J Am Vet Med Assoc; 2011 Jan; 238(2):195-206. PubMed ID: 21235373
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma.
Story AL; Boston SE; Kilkenny JJ; Singh A; Woods JP; Culp WTN; Skorupski KA; Lu X
J Vet Intern Med; 2017 Jul; 31(4):1159-1162. PubMed ID: 28503759
[TBL] [Abstract][Full Text] [Related]
16. Postoperative adjuvant combination therapy with doxorubicin and noncytotoxic suramin in dogs with appendicular osteosarcoma.
Alvarez FJ; Kisseberth W; Hosoya K; Lara-Garcia A; Kosarek C; Murahari S; Au JL; Wientjes MG; Couto J; Couto G
J Am Anim Hosp Assoc; 2014; 50(1):12-8. PubMed ID: 24216494
[TBL] [Abstract][Full Text] [Related]
17. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
Vail DM; Kurzman ID; Glawe PC; O'Brien MG; Chun R; Garrett LD; Obradovich JE; Fred RM; Khanna C; Colbern GT; Working PK
Cancer Chemother Pharmacol; 2002 Aug; 50(2):131-6. PubMed ID: 12172978
[TBL] [Abstract][Full Text] [Related]
18. Adverse events and outcomes in dogs with appendicular osteosarcoma treated with limb amputation and a single subcutaneous infusion of carboplatin.
Santamaria AC; Simcock JO; Kuntz CA
J Am Vet Med Assoc; 2019 Aug; 255(3):345-351. PubMed ID: 31298641
[TBL] [Abstract][Full Text] [Related]
19. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993).
Bergman PJ; MacEwen EG; Kurzman ID; Henry CJ; Hammer AS; Knapp DW; Hale A; Kruth SA; Klein MK; Klausner J; Norris AM; McCaw D; Straw RC; Withrow SJ
J Vet Intern Med; 1996; 10(2):76-81. PubMed ID: 8683484
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma.
Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM
J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
